- Home
- MYFW vs CRVS Comparison
MYFW vs CRVS Comparison
Compare MYFW & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYFW | CRVS |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.0M | 546.7M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MYFW | CRVS |
|---|---|---|
| Price | $26.17 | $7.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $24.25 | $13.75 |
| AVG Volume (30 Days) | 32.6K | ★ 1.6M |
| Earning Date | 01-22-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 391.62 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $95,514,000.00 | N/A |
| Revenue This Year | $15.96 | N/A |
| Revenue Next Year | $13.77 | N/A |
| P/E Ratio | $20.82 | ★ N/A |
| Revenue Growth | ★ 19.92 | N/A |
| 52 Week Low | $17.10 | $2.54 |
| 52 Week High | $28.00 | $9.60 |
Technical Indicators
Market Signals| Indicator | MYFW | CRVS |
|---|---|---|
| Relative Strength Index (RSI) | 64.09 | 39.32 |
| Support Level | $25.55 | $7.28 |
| Resistance Level | $28.00 | $7.86 |
| Average True Range (ATR) | 0.66 | 0.44 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 45.89 | 10.00 |
Price Performance
Historical ComparisonAbout MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).